Literature DB >> 32793695

RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population.

Bin Zhu1, Xingju Liu2,3,4, Xueke Zhen5, Xixi Li1, Mingfen Wu1, Yan Zhang2,3,4, Zhigang Zhao1, Dong Zhang2,3,4, Jizong Zhao2,3,4.   

Abstract

BACKGROUND: Gene polymorphism especially Ring Finger Protein 213 (RNF213) p.R4810K is one of the main cause of moyamoya disease (MMD) in Asian populations, especially among Japanese people. However, missense mutation may not explain the reduced frequency of MMD in Chinese patients. We performed a hospital based case-control study in a Chinese population to elucidate the possible underlying reasons.
METHODS: Five gene polymorphism loci, namely, rs35692831, rs9916351, rs9913636, rs8074015 and rs112735431, were included. A total of 98 patients and 114 healthy controls were enrolled in the study. Genomic DNA was genotyped by Mass Array methods.
RESULTS: A significant difference was observed between patients and healthy controls in rs9916351, rs9913636, and rs8074015 loci under three genotypes and allelic models (P<0.01). Logistic regression analysis revealed the significant differences under the dominant, recessive and additional model in rs9916351 [odds ratio (OR) =4.173, 95% confidence interval (CI): 2.290-7.606, P<0.001; OR =3.152, 95% CI: 1.585-6.267, P=0.001; OR =0.199, 95% CI: 1.727-3.764, P<0.001; respectively] and rs8074015 (OR =0.359, 95% CI: 0.206-0.627, P<0.001; OR =0.348, 95% CI: 0.148-0.81, P=0.015; OR =0.208, 95% CI: 0.311-0.703, P<0.001; respectively), even adjusting for age and gender. In addition, the haplotype rs9913636-rs8074015 under "GACG" showed significant association with MMD.
CONCLUSIONS: Our results had revealed the polymorphism of RNF213 rs9916351 and rs8074015 were significantly associated with MMD especially in Chinese population. 2020 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Moyamoya; RNF213; genetics; haplotype; polymorphism

Year:  2020        PMID: 32793695      PMCID: PMC7396805          DOI: 10.21037/atm-20-1040

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  23 in total

1.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.

Authors:  Fumiaki Kamada; Yoko Aoki; Ayumi Narisawa; Yu Abe; Shoko Komatsuzaki; Atsuo Kikuchi; Junko Kanno; Tetsuya Niihori; Masao Ono; Naoto Ishii; Yuji Owada; Miki Fujimura; Yoichi Mashimo; Yoichi Suzuki; Akira Hata; Shigeru Tsuchiya; Teiji Tominaga; Yoichi Matsubara; Shigeo Kure
Journal:  J Hum Genet       Date:  2010-11-04       Impact factor: 3.172

2.  Characteristics of Moyamoya Disease Based on National Registry Data in Japan.

Authors:  Yoko Sato; Ken Kazumata; Eiji Nakatani; Kiyohiro Houkin; Yasuhiro Kanatani
Journal:  Stroke       Date:  2019-06-25       Impact factor: 7.914

Review 3.  Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence.

Authors:  Shuo Huang; Zhen-Ni Guo; Mingchao Shi; Yi Yang; Mingli Rao
Journal:  Int J Stroke       Date:  2017-01-01       Impact factor: 5.266

Review 4.  The Susceptibility Pathogenesis of Moyamoya Disease.

Authors:  Juntao Hu; Jie Luo; Qianxue Chen
Journal:  World Neurosurg       Date:  2017-01-31       Impact factor: 2.104

5.  Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.

Authors:  Lian Duan; Ling Wei; Yanghua Tian; Zhengshan Zhang; Panpan Hu; Qiang Wei; Sugang Liu; Jun Zhang; Yuyang Wang; Desheng Li; Weizhong Yang; Rui Zong; Peng Xian; Cong Han; Xiangyang Bao; Feng Zhao; Jie Feng; Wei Liu; Wuchun Cao; Guoping Zhou; Chunyan Zhu; Fengqiong Yu; Weimin Yang; Yu Meng; Jingye Wang; Xianwen Chen; Yu Wang; Bing Shen; Bing Zhao; Jinghai Wan; Fengyu Zhang; Gang Zhao; Aimin Xu; Xuejun Zhang; Jianjun Liu; Xianbo Zuo; Kai Wang
Journal:  Stroke       Date:  2018-01       Impact factor: 7.914

Review 6.  Epidemiology, diagnosis and treatment of moyamoya disease.

Authors:  Hui Zhang; Lijian Zheng; Lei Feng
Journal:  Exp Ther Med       Date:  2019-01-25       Impact factor: 2.447

Review 7.  Moyamoya Disease.

Authors:  Miki Fujimura; Oh Young Bang; Jong S Kim
Journal:  Front Neurol Neurosci       Date:  2016-12-02

8.  Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis.

Authors:  Yanlan Huang; Daobin Cheng; Jiede Zhang; Weijia Zhao
Journal:  J Clin Neurosci       Date:  2016-08-08       Impact factor: 1.961

9.  Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.

Authors:  Hatasu Kobayashi; Yoshiko Matsuda; Toshiaki Hitomi; Hiroko Okuda; Hirotomo Shioi; Tetsuya Matsuda; Hirohiko Imai; Masakatsu Sone; Daisuke Taura; Kouji H Harada; Toshiyuki Habu; Yasushi Takagi; Susumu Miyamoto; Akio Koizumi
Journal:  J Am Heart Assoc       Date:  2015-06-30       Impact factor: 5.501

10.  Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease.

Authors:  Peicong Ge; Xun Ye; Xingju Liu; Xiaofeng Deng; Rong Wang; Yan Zhang; Dong Zhang; Qian Zhang; Jizong Zhao
Journal:  Front Neurol       Date:  2019-06-25       Impact factor: 4.003

View more
  4 in total

Review 1.  Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.

Authors:  Kirsten B Dorschel; John E Wanebo
Journal:  Appl Clin Genet       Date:  2021-03-18

2.  Ring finger protein 213 c.14576G>A mutation is not involved in internal carotid artery and middle cerebral artery dysplasia.

Authors:  Yasuo Murai; Eitaro Ishisaka; Atsushi Watanabe; Tetsuro Sekine; Kazutaka Shirokane; Fumihiro Matano; Ryuta Nakae; Tomonori Tamaki; Kenta Koketsu; Akio Morita
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

3.  DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.

Authors:  Adam J Kundishora; Samuel T Peters; Amélie Pinard; Daniel Duran; Shreyas Panchagnula; Tanyeri Barak; Danielle F Miyagishima; Weilai Dong; Hannah Smith; Jack Ocken; Ashley Dunbar; Carol Nelson-Williams; Shozeb Haider; Rebecca L Walker; Boyang Li; Hongyu Zhao; Dean Thumkeo; Arnaud Marlier; Phan Q Duy; Nicholas S Diab; Benjamin C Reeves; Stephanie M Robert; Nanthiya Sujijantarat; Amber N Stratman; Yi-Hsien Chen; Shujuan Zhao; Isabelle Roszko; Qiongshi Lu; Bo Zhang; Shrikant Mane; Christopher Castaldi; Francesc López-Giráldez; James R Knight; Michael J Bamshad; Deborah A Nickerson; Daniel H Geschwind; Shih-Shan Lang Chen; Phillip B Storm; Michael L Diluna; Charles C Matouk; Darren B Orbach; Seth L Alper; Edward R Smith; Richard P Lifton; Murat Gunel; Dianna M Milewicz; Sheng Chih Jin; Kristopher T Kahle
Journal:  JAMA Neurol       Date:  2021-08-01       Impact factor: 29.907

Review 4.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.